MED
Medifast Inc
Price:  
19.71 
USD
Volume:  
525,892.00
United States | Personal Products
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Medifast EV/EBITDA

323.7%
Upside

As of 2024-06-17, the EV/EBITDA ratio of Medifast Inc (MED) is 1.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Medifast's latest enterprise value is 118.16 mil USD. Medifast's TTM EBITDA according to its financial statements is 96.46 mil USD. Dividing these 2 quantities gives us the above Medifast EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 7.6x - 10.7x 9.0x
Forward P/E multiples 6.2x - 9.6x 8.0x
Fair Price 63.20 - 103.25 83.51
Upside 220.7% - 423.8% 323.7%
19.71 USD
Stock Price
83.51 USD
Fair Price

Medifast EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-17 1.23
2024-06-14 1.22
2024-06-13 1.27
2024-06-12 1.34
2024-06-11 1.43
2024-06-10 1.38
2024-06-07 1.42
2024-06-06 1.47
2024-06-05 1.49
2024-06-04 1.71
2024-06-03 1.82
2024-05-31 1.91
2024-05-30 1.95
2024-05-29 1.84
2024-05-28 1.80
2024-05-24 1.58
2024-05-23 1.57
2024-05-22 1.77
2024-05-21 1.76
2024-05-20 1.76
2024-05-17 1.82
2024-05-16 1.87
2024-05-15 1.87
2024-05-14 1.99
2024-05-13 1.86
2024-05-10 1.82
2024-05-09 1.91
2024-05-08 1.82
2024-05-07 1.88
2024-05-06 1.85
2024-05-03 2.02
2024-05-02 1.93
2024-05-01 1.98
2024-04-30 2.11
2024-04-29 3.02
2024-04-26 2.81
2024-04-25 2.79
2024-04-24 2.80
2024-04-23 2.78
2024-04-22 2.69
2024-04-19 2.67
2024-04-18 2.67
2024-04-17 2.61
2024-04-16 2.65
2024-04-15 2.55
2024-04-12 2.56
2024-04-11 2.61
2024-04-10 2.61
2024-04-09 2.85
2024-04-08 2.75